320 related articles for article (PubMed ID: 26942464)
1. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Li X; Gao Y; Zhang Y; Xie Y; Zhang X
Oncotarget; 2016 May; 7(22):31926-42. PubMed ID: 26942464
[TBL] [Abstract][Full Text] [Related]
2. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
Wang X; Su S; Guo Y
Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
5. Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis.
Hu RJ; Liu Q; Ma JY; Zhou J; Liu G
Clin Chim Acta; 2018 Sep; 484():1-6. PubMed ID: 29775617
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Templeton AJ; McNamara MG; Šeruga B; Vera-Badillo FE; Aneja P; Ocaña A; Leibowitz-Amit R; Sonpavde G; Knox JJ; Tran B; Tannock IF; Amir E
J Natl Cancer Inst; 2014 Jun; 106(6):dju124. PubMed ID: 24875653
[TBL] [Abstract][Full Text] [Related]
7. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
[TBL] [Abstract][Full Text] [Related]
9. The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with urological cancers: A meta-analysis.
Li M; Deng Q; Zhang L; He S; Rong J; Zheng F
Pathol Res Pract; 2019 Jan; 215(1):5-11. PubMed ID: 30401580
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: A meta-analysis.
Song W; Wang K; Zhang RJ; Zou SB
Medicine (Baltimore); 2016 Dec; 95(49):e5540. PubMed ID: 27930549
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis.
Li W; Tao L; Zhang L; Xiu D
Onco Targets Ther; 2017; 10():3391-3397. PubMed ID: 28744143
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis.
Lee SF; Ng TY; Spika D
BMC Cancer; 2019 Apr; 19(1):338. PubMed ID: 30971203
[TBL] [Abstract][Full Text] [Related]
13. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis.
Wei D; Liu J; Ma J
PeerJ; 2023; 11():e16014. PubMed ID: 37719125
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-to-monocyte ratio in pancreatic cancer: Prognostic significance and meta-analysis.
Hu RJ; Ma JY; Hu G
Clin Chim Acta; 2018 Jun; 481():142-146. PubMed ID: 29544747
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.
Wang Y; Xu C; Zhang Z
BMC Med; 2023 Dec; 21(1):486. PubMed ID: 38053096
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.
Li J; Cheng Y; Ji Z
Medicine (Baltimore); 2019 Jan; 98(2):e14091. PubMed ID: 30633220
[TBL] [Abstract][Full Text] [Related]
17. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis.
Hu G; Liu G; Ma JY; Hu RJ
Clin Chim Acta; 2018 Nov; 486():44-48. PubMed ID: 30028962
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma.
Gao P; Peng W; Hu Y
Head Neck; 2022 Mar; 44(3):624-632. PubMed ID: 35050540
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis.
Jin J; Yang L; Liu D; Li WM
Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
